A blood disorder, hemoglobinopathy is an abnormal hemoglobin structure and one of the common diseases which is inherited. Hemoglobinopathy disorder causes nearly all genetic disorders associated with hemoglobin and is categorized into two types, namely structural hemoglobin variants also known as abnormal hemoglobins and thalassemia syndromes. The most common hemoglobinopathy disorder include hemoglobin C disease, sickle-cell disease, and thalassemia.
Those people who used to only inherit the uncommon hemoglobin gene either one from mother or father are known as “Carriers” and they don’t have inherited disorder and are healthy also. According to World Health Organization, 2.9% of adults are carrier of thalassemia, 5% for hemoglobin condition, and 2.3% for sickle cell. And globally these figures are the result of migration of various groups from different regions. Besides, it was also found that about 1% of couples across the globe are at threat of having children with the blood disorder called hemoglobinopathy.
A hemoglobinopathy evaluation is the process used for detecting abnormal level of hemoglobin as well as protein present in RBCs that transports oxygen. This testing is basically used for screening and diagnosis.
Screening– In all states, there is a need that newly born babies should be screened for certain variations related to hemoglobin. Often, prenatal screening is done on high-risk parents who have an ethnic background related with higher incidences of hemoglobin abnormality and also who are affected through their family members. Screening might also be performed while having genetic counseling which is done prior to pregnancy for determining whether parents are carriers or not. Also, screening is done for identifying variations in asymptomatic parents of affected child.
Diagnosis– In order to identify the blood disorder, hemoglobinopathy, diagnosis is done in those patients having symptoms of abnormal results on CBC (complete blood count).
Globally, the market of hemoglobinopathy is growing significantly due to rapid development of point-of-care diagnostic methods, increasing prevalence of hemoglobinopathies in developed countries, several supportive government initiatives, preventive cost-effective approach, growing disease occurrence in underdeveloped countries and non-governmental organizational funding. However, lack of awareness about hemoglobinopathy disorders in underdeveloped nations, lack of specific diagnostic test and high sensitivity are hindering the market growth of hemoglobinopathy.
Moreover, it has been witnessed that annually there are so many cases of conceptions and deficiency of iron in children owing to poverty conditions which are responsible for boosting the market growth. Highly populated countries are facing problems in accessing healthcare related facilities and lack of awareness related with counselling is hindering the global market. Problems associated with hemoglobin can cause key health issues such as anemia and malaria can be cured if diagnosed at an initial stage.
For more iformation kindly visit @ http://www.persistencemarketresearch.com/market-research/hemoglobinopathy-market.asp
Furthermore, owing to development in the sector of healthcare, simple as well as cheap ways of testing new-born as well as adults is performed. In several low income countries, counselling facilities are provided for spreading awareness among people, promoting prenatal diagnosis as well as reassuring child’s birth. In the US and Europe region, most health insurance organizations, under the CPT code, provide health insurance coverage for the therapy of hemoglobinopathy which creates a positive environment for the market growth globally.